This is the first MR study to provide causal evidence that blood lipid levels mediated a considerable proportion of serum SHBG effect on CHD risk, and extensive sensitivity analyses were conducted to assess the robustness of the results. This evidence concerns the gene SHBG and coronary artery disorder.